CBD defended by Congress
Marijuana Business Daily has reported that 28 members of Congress have filed a brief to go along with the pending lawsuit against the DEA for keeping cannabidiol (CBD) a schedule 1 drug. The 9th Circuit Court of Appeals is set to hear arguments February 15th. The Congress members argue...